Paperpal Prime Logo

Lupus Science and Medicine : Impact Factor & More

eISSN: 2053-8790pISSN: 2053-8790
JournalOpen Access

Key Metrics

CiteScore
5.6
Eigenfactor
0.001 - 0.005
Impact Factor
< 5
SJR
Q3Immunology
SNIP
1.3
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Lupus Science and Medicine

Lupus Science and Medicine Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher BMJ PUBLISHING GROUP
Language English
Frequency Continuous publication
Article Processing ChargesGBP 2060
Publication Time15
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
Society/Institute/SponsorLupus Foundation of America (LFA)
FrequencyContinuous publication
Publication Start Year2014
Publisher URLVisit website
Website URLVisit website
Publication Details
Other chargesVisit website
PlagiarismVisit website
Publication Time 15
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY-NC, CC BY, CC BY-NC-ND
OA statementVisit website
View less

Planning to publish in Lupus Science and Medicine ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Lupus Science and Medicine

Are RAS inhibitors necessary during intensive immunosuppression for lupus nephritis? Real-world evidence from the STAR cohort.
  • 30 Jun 2026
  • Lupus science & medicine
Increasing the utilisation of hydroxychloroquine blood level testing in lupus: a quality improvement project.
  • 29 Jun 2026
  • Lupus science & medicine
Antiphospholipid syndrome in the paediatric population: performance of ACR-EULAR classification criteria in a controlled cohort.
  • 29 Jun 2026
  • Lupus science & medicine
Effects of exercise interventions on core health outcomes in patients with SLE: systematic review and meta-analysis.
  • 29 Jun 2026
  • Lupus science & medicine
Old marker, new face: anti-RNP as a sentinel of coronary and peripheral endothelial dysfunction in systemic lupus erythematosus.
  • 29 Jun 2026
  • Lupus science & medicine
Type I interferons enhance B cell activation and promote differentiation of double negative 2 cells in SLE.
  • 28 Jun 2026
  • Lupus science & medicine
Are RAS inhibitors necessary during intensive immunosuppression for lupus nephritis? Real-world evidence from the STAR cohort.
  • 30 Jun 2026
  • Lupus science & medicine
Increasing the utilisation of hydroxychloroquine blood level testing in lupus: a quality improvement project.
  • 29 Jun 2026
  • Lupus science & medicine
Antiphospholipid syndrome in the paediatric population: performance of ACR-EULAR classification criteria in a controlled cohort.
  • 29 Jun 2026
  • Lupus science & medicine
Effects of exercise interventions on core health outcomes in patients with SLE: systematic review and meta-analysis.
  • 29 Jun 2026
  • Lupus science & medicine
Old marker, new face: anti-RNP as a sentinel of coronary and peripheral endothelial dysfunction in systemic lupus erythematosus.
  • 29 Jun 2026
  • Lupus science & medicine
Type I interferons enhance B cell activation and promote differentiation of double negative 2 cells in SLE.
  • 28 Jun 2026
  • Lupus science & medicine

FAQs on Lupus Science and Medicine